Role of noncoding RNA in drug resistance of prostate cancer

被引：58

作者：

Ding, Lifeng ^{[1
]}

Wang, Ruyue ^{[1
]}

Shen, Danyang ^{[1
]}

Cheng, Sheng ^{[1
]}

Wang, Huan ^{[1
]}

Lu, Zeyi ^{[1
]}

Zheng, Qiming ^{[1
]}

Wang, Liya ^{[1
]}

Xia, Liqun ^{[1
]}

Li, Gonghui ^{[1
]}

机构：

[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Urol, Sch Med, Hangzhou, Peoples R China

来源：

CELL DEATH & DISEASE | 2021年 / 12卷 / 06期

基金：

中国国家自然科学基金;

关键词：

DOCETAXEL RESISTANCE; CASTRATION RESISTANCE; PACLITAXEL RESISTANCE; CELL-PROLIFERATION; CIRCULAR RNAS; UP-REGULATION; CHEMOSENSITIVITY; MECHANISMS; EXPRESSION; PATHWAY;

D O I：

10.1038/s41419-021-03854-x

中图分类号：

Q2 [细胞生物学];

学科分类号：

071013 [干细胞生物学];

摘要：

Prostate cancer is one of the most prevalent forms of cancer around the world. Androgen-deprivation treatment and chemotherapy are the curative approaches used to suppress prostate cancer progression. However, drug resistance is extensively and hard to overcome even though remarkable progress has been made in recent decades. Noncoding RNAs, such as miRNAs, lncRNAs, and circRNAs, are a group of cellular RNAs which participate in various cellular processes and diseases. Recently, accumulating evidence has highlighted the vital role of non-coding RNA in the development of drug resistance in prostate cancer. In this review, we summarize the important roles of these three classes of noncoding RNA in drug resistance and the potential therapeutic applications in this disease.

引用

页数：10

共 109 条

[1]

Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1 [J].

Abdelmohsen, Kotb ;

Panda, Amaresh C. ;

Munk, Rachel ;

Grammatikakis, Ioannis ;

Dudekula, Dawood B. ;

De, Supriyo ;

Kim, Jiyoung ;

Noh, Ji Heon ;

Kim, Kyoung Mi ;

Martindale, Jennifer L. ;

Gorospe, Myriam .

RNA BIOLOGY, 2017, 14 (03) :361-369

[2]

Non-coding RNA networks in cancer [J].

Anastasiadou, Eleni ;

Jacob, Leni S. ;

Slack, Frank J. .

NATURE REVIEWS CANCER, 2018, 18 (01) :5-18

[3]

MicroRNA-181a promotes docetaxel resistance in prostate cancer cells [J].

Armstrong, Cameron M. ;

Liu, Chengfei ;

Lou, Wei ;

Lombard, Alan P. ;

Evans, Christopher P. ;

Gao, Allen C. .

PROSTATE, 2017, 77 (09) :1020-1028

[4]

Improving the outcome of patients with castration-resistant prostate cancer through rational drug development [J].

Attard, G. ;

Sarker, D. ;

Reid, A. ;

Molife, R. ;

Parker, C. ;

de Bono, J. S. .

BRITISH JOURNAL OF CANCER, 2006, 95 (07) :767-774

[5]

Prostate cancer [J].

Attard, Gerhardt ;

Parker, Chris ;

Eeles, Ros A. ;

Schroder, Fritz ;

Tomlins, Scott A. ;

Tannock, Ian ;

Drake, Charles G. ;

de Bono, Johann S. .

LANCET, 2016, 387 (10013) :70-82

[6]

Long Non-coding RNA SNHG17 Promotes Cell Proliferation and Invasion in Castration-Resistant Prostate Cancer by Targeting the miR-144/CD51 Axis [J].

Bai, Minghua ;

Lei, Yutiantian ;

Wang, Mincong ;

Ma, Jinlu ;

Yang, Pengtao ;

Mou, Xingyi ;

Dong, Yiping ;

Han, Suxia .

FRONTIERS IN GENETICS, 2020, 11

[7]

LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells [J].

Bai, Tianliang ;

Liu, Yabin ;

Li, Binghui .

IUBMB LIFE, 2019, 71 (10) :1537-1551

[8]

CYPROTERONE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC EFFICACY IN PROSTATE-CANCER [J].

BARRADELL, LB ;

FAULDS, D .

DRUGS & AGING, 1994, 5 (01) :59-80

[9]

Long Noncoding RNA and Cancer: A New Paradigm [J].

Bhan, Arunoday ;

Soleimani, Milad ;

Mandal, Subhrangsu S. .

CANCER RESEARCH, 2017, 77 (15) :3965-3981

[10]

Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]

← 1 2 3 4 5 6 7 8 9 10 →